Greco Theresa 4
4 · OptimizeRx Corp · Filed Dec 27, 2024
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Greco Theresa
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-12-23+15,528→ 50,873 total - Award
Stock Option
2024-12-23+29,153→ 29,153 totalExercise: $4.83From: 2025-12-23Exp: 2027-12-23→ Common Stock (29,153 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on December 23, 2025, which is the first anniversary of the date of grant.
- [F2]The stock option vests in three equal annual installments beginning December 23, 2025, the first anniversary of the grant date.